Logo image of CRK

COMSTOCK RESOURCES INC (CRK) Stock Fundamental Analysis

NYSE:CRK - New York Stock Exchange, Inc. - US2057683029 - Common Stock - Currency: USD

22.4  +0.25 (+1.13%)

After market: 22.4 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CRK. CRK was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. CRK has a bad profitability rating. Also its financial health evaluation is rather negative. CRK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CRK has reported negative net income.
CRK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CRK reported negative net income in multiple years.
In the past 5 years CRK always reported a positive cash flow from operatings.
CRK Yearly Net Income VS EBIT VS OCF VS FCFCRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CRK has a Return On Assets of -5.07%. This is in the lower half of the industry: CRK underperforms 76.78% of its industry peers.
CRK has a worse Return On Equity (-15.77%) than 77.25% of its industry peers.
Industry RankSector Rank
ROA -5.07%
ROE -15.77%
ROIC N/A
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
CRK Yearly ROA, ROE, ROICCRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 55.07%, CRK is in the better half of the industry, outperforming 63.51% of the companies in the same industry.
CRK's Gross Margin has declined in the last couple of years.
CRK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
CRK Yearly Profit, Operating, Gross MarginsCRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

0

2. Health

2.1 Basic Checks

CRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRK has more shares outstanding
The number of shares outstanding for CRK has been increased compared to 5 years ago.
Compared to 1 year ago, CRK has a worse debt to assets ratio.
CRK Yearly Shares OutstandingCRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CRK Yearly Total Debt VS Total AssetsCRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

CRK has an Altman-Z score of 1.11. This is a bad value and indicates that CRK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRK (1.11) is comparable to the rest of the industry.
CRK has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.44, CRK is not doing good in the industry: 74.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACCN/A
WACC9.5%
CRK Yearly LT Debt VS Equity VS FCFCRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.40 indicates that CRK may have some problems paying its short term obligations.
CRK's Current ratio of 0.40 is on the low side compared to the rest of the industry. CRK is outperformed by 91.47% of its industry peers.
A Quick Ratio of 0.40 indicates that CRK may have some problems paying its short term obligations.
CRK has a worse Quick ratio (0.40) than 88.63% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
CRK Yearly Current Assets VS Current LiabilitesCRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

CRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -127.27%.
The Revenue for CRK has decreased by -24.74% in the past year. This is quite bad
The Revenue has been growing by 10.28% on average over the past years. This is quite good.
EPS 1Y (TTM)-127.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%52.74%

3.2 Future

The Earnings Per Share is expected to grow by 105.48% on average over the next years. This is a very strong growth
CRK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.22% yearly.
EPS Next Y404.93%
EPS Next 2Y167.69%
EPS Next 3Y98.4%
EPS Next 5Y105.48%
Revenue Next Year44.73%
Revenue Next 2Y32.1%
Revenue Next 3Y22.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRK Yearly Revenue VS EstimatesCRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CRK Yearly EPS VS EstimatesCRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRK. In the last year negative earnings were reported.
CRK is valuated rather expensively with a Price/Forward Earnings ratio of 18.07.
The rest of the industry has a similar Price/Forward Earnings ratio as CRK.
CRK is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 18.07
CRK Price Earnings VS Forward Price EarningsCRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRK is valued a bit more expensive than the industry average as 60.66% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.91
CRK Per share dataCRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRK's earnings are expected to grow with 98.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y167.69%
EPS Next 3Y98.4%

4

5. Dividend

5.1 Amount

CRK has a Yearly Dividend Yield of 4.74%, which is a nice return.
CRK's Dividend Yield is a higher than the industry average which is at 6.41.
Compared to an average S&P500 Dividend Yield of 2.35, CRK pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.74%

5.2 History

CRK has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CRK Yearly Dividends per shareCRK Yearly Dividends per shareYearly Dividends per share 2022 2023 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

DP0%
EPS Next 2Y167.69%
EPS Next 3Y98.4%
CRK Yearly Income VS Free CF VS DividendCRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

COMSTOCK RESOURCES INC

NYSE:CRK (7/11/2025, 8:04:00 PM)

After market: 22.4 0 (0%)

22.4

+0.25 (+1.13%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners30.67%
Inst Owner Change0%
Ins Owners2.17%
Ins Owner Change0.27%
Market Cap6.56B
Analysts55.65
Price Target21.69 (-3.17%)
Short Float %27.95%
Short Ratio9.23
Dividend
Industry RankSector Rank
Dividend Yield 4.74%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)282.75%
Min EPS beat(2)14.38%
Max EPS beat(2)551.11%
EPS beat(4)2
Avg EPS beat(4)134.58%
Min EPS beat(4)-22.17%
Max EPS beat(4)551.11%
EPS beat(8)3
Avg EPS beat(8)57.37%
EPS beat(12)5
Avg EPS beat(12)40.14%
EPS beat(16)7
Avg EPS beat(16)30.61%
Revenue beat(2)1
Avg Revenue beat(2)8.81%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)20.2%
Revenue beat(4)1
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-17.72%
Max Revenue beat(4)20.2%
Revenue beat(8)3
Avg Revenue beat(8)-1.61%
Revenue beat(12)7
Avg Revenue beat(12)20.57%
Revenue beat(16)11
Avg Revenue beat(16)21.28%
PT rev (1m)6.33%
PT rev (3m)16.76%
EPS NQ rev (1m)-18.62%
EPS NQ rev (3m)-21.96%
EPS NY rev (1m)-4.62%
EPS NY rev (3m)11.56%
Revenue NQ rev (1m)-1.35%
Revenue NQ rev (3m)1.29%
Revenue NY rev (1m)-1.74%
Revenue NY rev (3m)1.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.07
P/S 4.59
P/FCF N/A
P/OCF 10.52
P/B 3.09
P/tB 3.67
EV/EBITDA 12.91
EPS(TTM)-0.03
EYN/A
EPS(NY)1.24
Fwd EY5.53%
FCF(TTM)-1.44
FCFYN/A
OCF(TTM)2.13
OCFY9.5%
SpS4.88
BVpS7.24
TBVpS6.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -15.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.07%
FCFM N/A
ROA(3y)6.49%
ROA(5y)2.42%
ROE(3y)15.97%
ROE(5y)4.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.34%
GM growth 5Y-6.76%
F-Score2
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 4.11
Cap/Depr 135.13%
Cap/Sales 72.97%
Interest Coverage N/A
Cash Conversion 84.02%
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 1.11
F-Score2
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)196.86%
Cap/Depr(5y)171.92%
Cap/Sales(3y)69.34%
Cap/Sales(5y)60.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-127.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%700%
EPS Next Y404.93%
EPS Next 2Y167.69%
EPS Next 3Y98.4%
EPS Next 5Y105.48%
Revenue 1Y (TTM)-24.74%
Revenue growth 3Y-12.18%
Revenue growth 5Y10.28%
Sales Q2Q%52.74%
Revenue Next Year44.73%
Revenue Next 2Y32.1%
Revenue Next 3Y22.22%
Revenue Next 5YN/A
EBIT growth 1Y-114.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2445.91%
EBIT Next 3Y221.93%
EBIT Next 5Y145.7%
FCF growth 1Y-173.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-65.37%
OCF growth 3Y-10.28%
OCF growth 5Y6.57%